“crispr” Archives

in
Entry Author Date Location
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles 07/25/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Broad, Berkeley Return to Argue CRISPR Invention at Patent Office 06/25/19 National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death 06/03/19 National
ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists 05/16/19 San Diego
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September 05/16/19 Boston
Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO 04/30/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs 03/27/19 Raleigh Durham
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M 03/21/19 Boston
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs 03/06/19 Boston
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More 01/25/19 National
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial 01/22/19 Boston
From Alnylam to Zayner: Xconomy’s Top Innovation Stories of 2018 12/27/18 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Pre-Existing Immunity to CRISPR Found in 96% of People in Study 10/29/18 Boston
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
LogicBio Jumps on the Gene Therapy 2.0 Wave and Lines Up an IPO 09/26/18 Boston
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Gilead Partners with Precision Bio in Search of Gene-Editing HBV Cure 09/12/18 San Francisco
Sangamo 1st to Show Human Gene-Editing Results. Investors Say ‘Meh.’ 09/05/18 San Francisco
Page 2 of 4 « previous page · next page »